Nephros (NEPH) Operating Expenses (2010 - 2026)

Nephros' Operating Expenses history runs 17 years deep, the most recent figure standing at $2.9 million for Q1 2026.

• In Q1 2026, Operating Expenses rose 11.9% year-over-year to $2.9 million; the TTM figure through Mar 2026 stood at $10.8 million (up 20.96% YoY), while the FY2025 annual figure was $10.5 million, up 20.21% from the prior year.
• Operating Expenses was $2.9 million for Q1 2026 at Nephros, up from $2.7 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $2.9 million in Q1 2026 to a low of $1.9 million in Q3 2024.
• Historically, Operating Expenses has averaged $2.4 million across 5 years, with a median of $2.4 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Operating Expenses declined 19.18% in 2024, then jumped 33.87% in 2025.
• A 5-year view of Operating Expenses shows it stood at $2.2 million in 2022, then increased by 21.25% to $2.7 million in 2023, then retreated by 19.18% to $2.2 million in 2024, then climbed by 27.11% to $2.7 million in 2025, then rose by 5.58% to $2.9 million in 2026.
• The last three Operating Expenses figures came in at $2.9 million (Q1 2026), $2.7 million (Q4 2025), and $2.6 million (Q3 2025), per Business Quant data.